Edition:
India

Aurora Cannabis Inc (ACB.TO)

ACB.TO on Toronto Stock Exchange

9.13CAD
15 Jul 2019
Change (% chg)

-- (--)
Prev Close
$9.13
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
8,683,843
52-wk High
$16.24
52-wk Low
$5.29

Summary

Name Age Since Current Position

Michael Singer

2019 Executive Chairman of the Board

Steve Dobler

President, Director

Terry Booth

2014 Chief Executive Officer, Director

Glen Ibbott

2017 Chief Financial Officer

Allan Cleiren

2017 Chief Operational Officer

Debra Wilson

2018 Chief Human Resource Officer

Carey Squires

2019 Executive Vice President of Corporate Development and Strategy

Andre Jerome

2018 Senior Vice President - Business Integration

Shane Morris

2018 Senior Vice President - Product Development and Regulatory Affairs

Nilda Rivera

2017 Vice President - Finance, Corporate Secretary

Dieter MacPherson

2017 Vice President - Production

Kelly Narine

2018 Vice President - Research

Nick Whitehead

2017 Vice President - Market Development

Cameron Battley

2018 Chief Corporate Officer

Neil Belot

2017 Chief Global Business Development Officer

Darren Karasiuk

2019 Chief Commercial Officer

Jonathan Page

2018 Chief Science Officer

Jillian Swainson

2019 Chief Legal Officer and Corporate Secretary

Ronald Funk

2019 Lead Independent Director

Norma Beauchamp

2018 Director

Margaret Atkins

62 2019 Independent Director

Jason Dyck

2015 Independent Director

Adam Szweras

47 2015 Independent Director

Marc Lakmaaker

2018 VP, Investor Relations

Biographies

Name Description

Michael Singer

Mr. Michael Singer is Executive Chairman of the Board of the company. he was Chairman of the Board of the Company. He has Chartered Professional Accountant (CPA, CGA), Consultant and Entrepreneur; CFO of Clementia Pharmaceuticals Inc. since May 2015; CFO of Bedrocan Cannabis Corp. from May 2014 to June 2015; and CFO of Thallion Pharmaceuticals Inc. from March 2007 to August 2013.

Steve Dobler

Mr. Steve Dobler is President, Director of the Company. He is Professional Engineer; Vice President and part owner of Superior Safety Codes Inc.; President of ICC Enterprises Corp. since May 2002.

Terry Booth

Mr. Terry Booth is Chief Executive Officer, Director of the Company. He was President and part owner of Superior Safety Codes Inc.

Glen Ibbott

Mr. Glen Ibbott is a Chief Financial Officer of the Company. He is a seasoned senior health care executive with over 20 years of experience providing financial leadership to various public entities, including management of Canadian and international capital market strategies, mergers and acquisitions, and tax and finance, predominantly within the life sciences sector. An innovative, decisive and insightful professional, he has excelled in delivering revenue and profitability growth, both domestically and internationally, strategy execution and shareholder value creation, including key contributions to numerous corporate transactions. Most recently, Mr. Ibbott was CFO at QLT Inc, a Nasdaq Stock Market- and Toronto Stock Exchange-listed biopharmaceutical company, and played a key role in QLT's $500-million merger with Aegerion Pharmaceuticals to form Novelion Therapeutics. Prior to his time at QLT, Mr. Ibbott held various senior finance positions, including with globally operating companies such as Nordion, International Forest Products, Angiotech Pharmaceuticals, Aspreva Pharmaceuticals and Inex Pharmaceuticals. Earlier in his career, he worked within the technology practice of KPMG. Mr. Ibbott completed MBAs at Cornell University and at Queen's University, is a Canadian chartered professional accountant (CPA, CA), as well as a U.S. CPA, and holds a bachelor of business administration from Simon Fraser University.

Allan Cleiren

Mr. Allan Cleiren is Chief Operational Officer of the Company. He has nearly three decades of leadership experience in finance and operations management with both privately and publicly held companies in the life sciences, insurance, rail, construction, oil and gas service, and other sectors. Through various senior positions, he has held responsibility for all aspects of operations, including manufacturing, logistics, human resources, IT, and marketing. As a senior financial executive, Mr. Cleiren also has considerable experience in M&A and restructuring. Throughout his career, Mr. Cleiren's focus has been on achieving operational excellence and efficiency, contributing to significant revenue and profitability growth. Most recently, Mr. Cleiren was COO with Jardine Lloyd Thompson Canada Inc. (JLT), one of the world's leading providers of insurance, reinsurance and employee benefits related advice, brokerage and associated services. Prior to joining JLT, he served as Executive Vice President and formerly CFO for Universal Rail Systems Inc, and as Senior Vice President of Operations and CFO for Afexa Life Sciences. He is a member of the Board of Directors of Universal Rail Services Inc., Metalogic Inspection Services Inc., and is Chair of the Board for the Alberta Automobile Insurance Rate Board. Mr. Cleiren is a Chartered Professional Accountant (CPA, CA), holds a Bachelor of Commerce from the University of Alberta, and has a Diploma in Management Sciences from the Grant MacEwan College in Alberta. Mr. Cleiren also holds a ICD.D designation through the Institute of Corporate Directors.

Debra Wilson

Dr. Debra Wilson is Chief Human Resource Officer of the Company. Dr. Wilson joined the Company in June, 2017 and previously served as Vice President and Senior Vice President of Human Resources. She is a seasoned leader with more than 25 years' experience in human resources, developing and practicing leading edge methods. Debra earned her PhD in industrial and organizational psychology from Capella University, and her MBA from Royal Roads University, with a concentration in Human Resource Management. Believing strongly in professional development, Debra is also an adjunct instructor for courses in Human Resource at the Northern Alberta Institute of Technology (NAIT). Prior to joining Aurora, Debra was a leader in the areas of Human Resources and Organizational Development for various organizations across several industries. Debra was Director of Human Resources for Universal Rail Systems, a specialized rail construction and maintenance company with offices across Canada. Prior to that, Debra was Vice President of Human Resources and Organizational Development at Alberta Pensions Services Corporation, Senior Director of HR and Administration for Afexa Life Sciences, Vice President of Human Resources for Maclab Enterprises Inc. and Vice President of Human Resources for Bentall Kennedy.

Carey Squires

Mr. Carey Squires is Executive Vice President of Corporate Development and Strategy of the company. Mr. Squires comes to Aurora with global investment banking experience, having most recently served as Managing Director and Co-Head of Equity-Linked Capital Markets for BMO Capital Markets. In this role, he successfully led the financing for a number of issuers, including Aurora's recent convertible notes offering. Mr. Squires received a B.Sc from the University of British Columbia as well as an MBA from the Rotm an School of Management at the University of Toronto.

Andre Jerome

Mr. Andre Jerome is a Senior Vice President - Business Integration of the Company. Mr. Jerome, a member of the Bar of Quebec for the last 23 years, joins Aurora from H2 Biopharma Inc ("H2"), where he was CEO and co-founder. H2 is a Quebec-based, late-stage applicant for Licensed Producer status, which was acquired by Aurora in November 2017. Prior to his activities in the cannabis industry, Mr. Jerome spent over two decades in the telecoms industry. He held various senior executive positions in corporate affairs, playing an important role in acquisition integration with, among others, international telecom giant Vodafone.

Shane Morris

Mr. Shane Morris is Senior Vice President - Product Development and Regulatory Affairs of the company. He had been the Vice-President in this role previously. Dr. Morris and his team are responsible for numerous product innovations at Aurora, including the recent launch ofAurora Cloud, the industry's only vape-ready CBD oil cartridge available on the Canadian medical cannabis market.

Nilda Rivera

Ms. Nilda Rivera is Vice President - Finance, Corporate Secretary of the Company. She was Vice President, Finance of Aurora; Controller of Aurora from August 2015 to July 31, 2017; and CFO of Avarone Metals Inc. from June 2010 to August 2015.

Dieter MacPherson

Mr. Dieter MacPherson is Vice President - Production of the Company. He is Manager of Production at Aurora from February 2017 to July 31, 2017; General Manager at Trees Dispensary from February 2015 to January 2017; Executive Director at Victoria Cannabis Buyers Club from March 2013 to February 2015; Shift Manager at Victoria Cannabis Buyers Club from January 2012 to March 2013.

Kelly Narine

Nick Whitehead

Mr. Nick Whitehead is Vice President - Market Development of the Company. He is ; Manager of Public Affairs at Aurora from January 2016 to July 2017; Director of Organizing for Sensible BC Campaign January 2013 to January 2016; Junior Transportation Planner at McCormick-Rankin Corporation May 2012 to September 2012.

Cameron Battley

Mr. Cameron Battley serves as Chief Corporate Officer of the Company. Mr. Battley is President of Health Strategy Group Inc. from January 1998 to March 2016.

Neil Belot

Mr. Neil Belot is Chief Global Business Development Officer of the Company. He was Chief Brand Officer at Aurora from September 8, 2015 to March 20, 2017; Executive Director of Canadian Medical Cannabis Industry Association from November 2014 to September 2015; Gas Portfolio & Energy Services Manager of Housing Services Corp. from September 2012 to September 2014.

Darren Karasiuk

Mr. Darren Anthony Karasiuk is Chief Commercial Officer of the company. he was Executive Vice President - Adult Usage of the Company. Mr. Karasiuk joins Aurora through the acquisition of MedReleaf where he was Senior Vice-President and GM, recreational where he was responsible for MedReleaf's adult use cannabis business which included the development and introduction of the AltaVie and San Rafael '71 brands into the marketplace, as well as the stewardship of the partnership with the Woodstock Cannabis Company. Mr. Karasiuk has deep experience in highly regulated industries, including private and public healthcare, pharma, tobacco, consumer packaged goods, and energy. Prior to joining MedReleaf, Mr. Karasiuk was Vice-President, Insights and Advisory at Deloitte where he was a leader in the firm's cannabis practice, co-authoring the firm's seminal study, "Recreational Marijuana: Insights and Opportunities." Previously, Mr. Karasiuk was Vice-President, Strategy, Corporate and Public Affairs at Environics Research, where he conducted many of Canada's earliest engagements on the cannabis sector. He has also been the Canadian associate for the Marijuana Policy Group, a leading Denver-based economic and policy consulting firm which helped shape the regulated medical and recreational cannabis markets. Mr. Karasiuk holds an MA from Western University and an MBA from Kellogg-Schulich.

Jonathan Page

Dr. Jonathan Page Ph.D., is Chief Science Officer of the company. He is a globally renowned cannabis scientist, with 37 peer-reviewed publications, who was the co-lead of the Canadian team of scientists who first sequenced the cannabis genome. His work also helped discover the biochemical pathways leading to the major cannabinoids. Prior to his appointment, Dr. Page served as CEO of recently acquired Anandia Labs, the world-leading cannabis-focused science company he co-founded.

Jillian Swainson

Ms. Jillian L. Swainson is Chief Legal Officer and Corporate Secretary of the company. she was Senior Vice President, General Counsel of the Company. Ms. Swainson joins Aurora from Brownlee LLP, where she was a Partner in the law firm's business practice and where she handled a variety of business law matters, including corporate, commercial, intellectual property, and securities work. In addition to her general practice of business law, over the past several years she has developed an expertise in providing general counsel and advisory services to clients within the heavily regulated and increasingly complex cannabis industry. She graduated from the University of Alberta with a Bachelor of Commerce degree in 2004, and a law degree (LL.B.) in 2007. She joined Brownlee as an articling student in 2007, and was called to the bar in 2008. Ms. Swainson is also a Registered Trade-mark Agent.

Ronald Funk

Mr. Ronald Funk is Lead Independent Director of the company. he was Director of the Company. He is Director of MedReleaf Corp.l and Consultant.

Norma Beauchamp

Ms. Norma Beauchamp is Director of the Company. She was Director of MedReleaf Corp., Board of Director, Acerus Pharma and Eve Medical; Past President and CEO, Cystic Fibrosis Canada; Past SVP Pharmaceuticals, Bayer Canada; Past VP, Global Strategic Marketing, Gynecology and Andrology, Bayer AG.

Margaret Atkins

Ms. Margaret Atkins, CPA is Independent Director of the company. The Company also appointed Shan Atkins as a new independent director and Chair of the Audit Committee. Ms. Atkins brings deep experience in public company governance and leadership in global retail and healthcare companies, such as Shoppers Drug Mart, Tim Hortons and Sears, Roebuck & Company. Her expertise in overseeing public company reporting for both large Canadian and U.S. listed companies will prove an important asset for Aurora, which is dual listed on the TSX and NYSE. Ms. Atkins brings over 20 years of corporate leadership of experience to Aurora. A Certified Public Accountant, she spent fourteen years at Bain & Company, where she became a partner and leader in the firm's global consumer and retail practice. She also maintained a secondary practice in healthcare, working in Rx and OTC pharmaceuticals and in the hospital industry. Ms. Atkins also served as Executive VP of Sears, Roebuck & Company (USA) and since 1999, she has served as an independent director on ten public and private corporate boards in the U.S. and Canada. She is currently on the boards of Darden (NYSE: DRI), SpartanNash (NASD: SPTN), SunOpta (NASD: STKL; TSX: SOY) and LSC Communications (NYSE: LKSD). Previously, Ms. Atkins served on the boards of Shoppers Drug Mart, Tim Hortons and The Pep Boys. She is a graduate of Queen's University and the Harvard Business School.

Jason Dyck

Dr. Jason R.B. Dyck, Ph.D., is Independent Director of Aurora Cannabis Inc. Mr. Dyck is a professor in the Department of Pediatrics, University of Alberta since July 1999; and VicePresident, Metabolic Modulators Research Ltd. since July 1999.

Adam Szweras

Mr. Adam K. Szweras is Independent Director of the Company. Mr. Szweras, LLB, is a partner at Fogler, Rubinoff LLP. He is currently Chairman of a merchant bank and serves as a director and/or officer and audit committee member for other publicly traded companies.

Marc Lakmaaker